Extended-release naltrexone and sublingual buprenorphine-naloxone appear to be equally safe and effe...

The Food and Drug Administration (FDA) on Monday approved Abilify MyCite—aripiprazole tablets with a...

The use of attention-deficit/hyperactivity disorder (ADHD) medications during pregnancy can modestly...

Antipsychotics are commonly used in hospitals for non-psychiatric purposes, particularly to manage d...

Incorporating a computerized cognitive-behavioral therapy (CCBT) into a collaborative care program m...

In response to remarks by President Donald Trump this week that the deadly shooting in a Texas churc...

By the time adults with intellectual disability sought specialized psychiatric outpatient services i...

APA today recognized five leaders in politics, journalism, and advocacy for drawing attention to the...

Following the release of the final report by the President’s Commission on Combating Drug Abuse and ...